Rapid Growth ProSomnus has demonstrated consistent growth, earning a spot on the Inc. 5000 list for four consecutive years and increasing its market presence in the medical device manufacturing sector. This rapid expansion indicates a strong market demand for its innovative non-CPAP sleep apnea therapies.

Expanding Product Portfolio The recent launch of EVO Guided and the pilot study of a next-generation Remote Patient Monitoring device showcase ProSomnus's commitment to product innovation, providing opportunities to cross-sell or upsell related devices and support services to healthcare providers and clinics.

Strong Market Coverage With FDA clearance and coverage by Medicare, TRICARE, and other government healthcare plans covering over 200 million lives, ProSomnus’s products are highly accessible, opening avenues for partnerships with insurance providers and healthcare networks to expand reach.

Partnership Opportunities ProSomnus has established strategic partnerships, such as with US ENT, creating a pathway for sales collaborations and joint marketing initiatives targeting ENT clinics, sleep clinics, and hospitals that seek innovative treatments for sleep apnea.

Technology and Data Integration The company’s use of advanced technology like Remote Patient Monitoring and clinical data-driven devices signals potential for developing integrated solutions and data services, appealing to healthcare providers focused on personalized and remote patient care models.